Table 5 Rate of leukopenia depending on perioperative factors
Missing, n | Leukopenia | No leukopenia | Total (n) | p-value | |
|---|---|---|---|---|---|
Neoadjuvant therapy: n (%) | 131 | ||||
Yes | 15 (11.0) | 121 (89.0) | 136 | 0.535 | |
No | 29 (9.1) | 288 (90.9) | 317 | ref. | |
Chemotherapy used in HIPEC: | 47 | ||||
Oxaliplatin, n (%) | 24 (6.1) | 371 (93.9) | 395 | ref. | |
Oxaliplatin + Irinotecan, n (%) | 17 (45.9) | 20 (54.1) | 37 | < 0.01 | |
Mitomycin C, n (%) | 5 (17.2) | 24 (82.8) | 29 | 0.026 | |
Irinotecan, n (%) | 5 (7.1) | 65 (92.9) | 70 | 0.719 | |
Other, n (%) | 2 (33.3) | 4 (66.7) | 6 | - | |
Missing data, n (%) | 1 (2.1) | 46 (97.9) | 47 | - | |
Operating time: | 0 | ||||
< 480 min | 18 (33.3) | 285 (53.8) | 303 | ref. | |
≥ 480 min | 36 (66.7) | 245 (46.2) | 281 | 0.004 |